๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group

โœ Scribed by M. M. Moore; M. Stockler; R. Lim; T. S. K. Mok; M. Millward; M. J. Boyer

Publisher
Springer
Year
2010
Tongue
English
Weight
228 KB
Volume
66
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II trial of estramustine and eto
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)
โœ Kenneth J. Pienta; Emily I. Fisher; Mario A. Eisenberger; Glenn M. Mills; J. Wen ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

BACKGROUND. The combination of oral estramustine and oral etoposide has generated response rates of 40ยฑ50% in patients with hormone refractory prostate cancer in single institution trials. This study tested this regimen in a multi-institutional setting. METHODS. Fifty-ยฎve patients were accrued over